Liqing Hu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Candida Albicans

Single Molecule

Pulmonary Arterial Hypertension

Top Venues

Nature communications

Journal of medicinal chemistry

Central South University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Central South University Sep 8o 2018

China

PHD :: Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Science

Publications

Liqing Hu, Cancan Sun, Justin M Kidd, Jizhong Han, Xianjun Fang, Hongtao Li, Qingdai Liu, Aaron E May, Qianbin Li, Lei Zhou, Qinglian Liu
A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungi. Nature communications 14 (1) (2023)
Liqing Hu, Cancan Sun, Justin M Kidd, Jizhong Han, Xianjun Fang, Hongtao Li, Qingdai Liu, Aaron E May, Qianbin Li, Lei Zhou, Qinglian Liu
A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungi. Nature communications 14 (1) (2023)
Liqing Hu, Lijun Li, Qi Chang, Songsen Fu, Jia Qin, Zhuo Chen, Xiaohui Li, Qinglian Liu, Gaoyun Hu, Qianbin Li
Discovery of Novel Pyrazolo[3,4-b] Pyridine Derivatives with Dual Activities of Vascular Remodeling Inhibition and Vasodilation for the Treatment of Pulmonary Arterial Hypertension. Journal of medicinal chemistry 63 (19) (2020)